The case for informative phase 2 trials in osteosarcoma

Katherine A. Janeway, Richard Gorlick

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Cite this

@article{d9f298ef72ee40b9a73bcd42631f2a8e,

title = "The case for informative phase 2 trials in osteosarcoma",

author = "Janeway, {Katherine A.} and Richard Gorlick",

year = "2016",

month = aug,

day = "1",

doi = "10.1016/S1470-2045(16)30293-5",

language = "English (US)",

volume = "17",

pages = "1022--1023",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "8",

}

TY - JOUR

T1 - The case for informative phase 2 trials in osteosarcoma

AU - Janeway, Katherine A.

AU - Gorlick, Richard

PY - 2016/8/1

Y1 - 2016/8/1

UR - http://www.scopus.com/inward/record.url?scp=84995933315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995933315&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(16)30293-5

DO - 10.1016/S1470-2045(16)30293-5

M3 - Comment/debate

AN - SCOPUS:84995933315

VL - 17

SP - 1022

EP - 1023

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 8

ER -